Investors

Bionamics represents an attractive investment opportunity to all investors, private and institutional, interested in a timely and rewarding investment into the life science sector.

Bionamics is focussed on the management of promising life science assets, with an emphasis on drug development themes, utilizing the advantages of distinguished CROs assigned with the operational project development to ensure a timely and cost efficient project progression.

Investments made are used to finance the development of the selected assets across major value inflections points (e.g. proof-of-concept in pre-clinical models, IND-filing, Phase-IIa execution) to generate added value and commercial viability. Investors are offered the unique opportunity of project-specific investments as well as investment into the entire corporate project portfolio.

With respect to the needs of our investors, we actively provide timely, accurate, and significant information as part of our implemented reporting system.